| Harold Harrington Cameron, MD | |
|
135 S Sharon Amity Rd, Ste 100, Charlotte, NC 28211-3870 | |
| (704) 365-0555 | |
| (704) 367-8122 |
| Full Name | Harold Harrington Cameron |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 54 Years |
| Location | 135 S Sharon Amity Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316951429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 16840 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Horizon Eye Care Pa | 2163484072 | 25 |
News Archive
Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.
Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.
Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists.
Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it.
› Verified 3 days ago
| Entity Name | Horizon Eye Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235192113 PECOS PAC ID: 2163484072 Enrollment ID: O20041102001221 |
News Archive
Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.
Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.
Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists.
Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold Harrington Cameron, MD Po Box 60160, Charlotte, NC 28260-0160 Ph: (252) 633-4183 | Harold Harrington Cameron, MD 135 S Sharon Amity Rd, Ste 100, Charlotte, NC 28211-3870 Ph: (704) 365-0555 |
News Archive
Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.
Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.
Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists.
Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it.
› Verified 3 days ago
Dr. Lisa Anne Collea, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3468 | |
Ernest M. Bhend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3121 | |
Dr. James Wesley Heroman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 497 N Wendover Rd, Charlotte, NC 28211 Phone: 704-376-5424 Fax: 704-376-5354 | |
Dr. Benjamin Charles Kramer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 135 S Sharon Amity Rd Ste 100, Charlotte, NC 28211 Phone: 704-365-0555 Fax: 704-367-8120 | |
Jeffrey Ryan Stetler, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3468 | |
Dr. Samuel Santander, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3621 Randolph Road, Suite 100, Charlotte, NC 28211 Phone: 704-332-9365 Fax: 704-364-7384 | |
Dr. Judy Diane Hustead, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 135 S Sharon Amity Rd, Suite 100, Charlotte, NC 28211 Phone: 704-365-0555 Fax: 704-367-8124 |